The CDC and FDA recommend that the Janssen vaccine be stopped.
U.S. Centers for Disease Control and Prevention (CDC) And the Food and Drug Administration (U.S. Food and Drug Administration) It is recommended to stop using the vaccine of Janssen, a subsidiary of Johnson & Johnson, a US multinational company, after 6 such cases have been recorded. Blood clot As reported by the US agency itself, “rare and serious.”
The FDA added: “The (U.S.) Federal Government prioritizes the safe vaccination of COVID19.” “We take seriously all reports of post-immunization health issues in response to the pandemic.”
As the organization explained in its statement on social networks, a decision must be made after registering on the social network. Blood clot case “Rarely” requires treatment outside of usual.
The CDC has already convened a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases, and the FDA will also review the analysis results, and both agencies have reported on social media.
Before the investigation is over, use vaccine.
They explained that in this way, the person in charge of medical treatment will also have time to understand possible adverse reactions and what is the best treatment.
According to CNN, the announcement of the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) means that all federal health channels previously vaccinated by Johnson & Johnson-mass vaccination sites, communities Health centers, etc.-This procedure must be temporarily suspended.
These agencies recommend that states do the same thing, but it is up to each country to make the decision.
After detecting a blood clot type that may not be on the list, vaccination was suspended Adverse side effects This is part of Johnson & Johnson’s emergency use authorization, assures the local media.
The six registered cases were women between the ages of 18 and 48, and their symptoms occurred 6 to 13 days later. Vaccination.
In the United States, in addition to Johnson & Johnson vaccine, one of the countries with the highest level of vaccination against covid-19 in the world has also been treated, including serums produced by Pfizer and Moderna.
The CDC and FDA will release more information about this announcement at a joint press conference on Tuesday.